Home › Compare › MRK vs BSX

MRK vs BSX: Dividend Comparison 2026

MRK yields 3.25% · BSX yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $2.7K in total portfolio value
10 years
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →
BSX
BSX
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full BSX calculator →

Portfolio growth — MRK vs BSX

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRKBSX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRK + BSX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MRK pays
BSX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
BSX
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, MRK beats the other by $43.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRK + BSX for your $10,000?

MRK: 50%BSX: 50%
100% BSX50/50100% MRK
Portfolio after 10yr
$29.4K
Annual income
$924.75/yr
Blended yield
3.15%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRK buys
0
BSX buys
0
No recent congressional trades found for MRK or BSX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRKBSX
Forward yield3.25%4.00% ✓
Annual dividend / share$3.08 ✓$2.00
Payout ratio42% ✓50%
1-year div growth5.5% ✓5%
5-year div CAGR8.2% ✓5%
Portfolio after 10y$30.7K ✓$28.0K
Annual income after 10y$950.29 ✓$899.19
Total dividends collected$6.1K$6.4K ✓
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare

Year-by-year: MRK vs BSX ($10,000, DRIP)

YearMRK PortfolioMRK Income/yrBSX PortfolioBSX Income/yrGap
1← crossover$11,192$351.54$11,120$420.00+$72.00 → MRK
2$12,524$392.70$12,357$458.31+$167.00 → MRK
3$14,015$438.65$13,721$499.76+$294.00 → MRK
4$15,682$489.96$15,227$544.58+$455.00 → MRK
5$17,547$547.23$16,885$593.02+$662.00 → MRK
6$19,632$611.16$18,713$645.34+$919.00 → MRK
7$21,963$682.53$20,724$701.81+$1.2K → MRK
8$24,571$762.18$22,938$762.73+$1.6K → MRK
9$27,486$851.08$25,372$828.41+$2.1K → MRK
10$30,745$950.29$28,047$899.19+$2.7K → MRK

MRK vs BSX: Complete Analysis 2026

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

BSX — Healthcare

BSX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in BSX shares.

Full BSX Calculator →
📬

Get this MRK vs BSX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRK vs JNJMRK vs ABBVMRK vs PFEMRK vs BMYMRK vs LLYMRK vs SCHDMRK vs JEPIMRK vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.